Sensus Healthcare Launches Collaboration with BirchBioMed

Press Release

Sensus Healthcare Launches Collaboration with BirchBioMed to Treat and Prevent Scarring for Keloids Patients Around the World

On February 5th, 2018, Sensus Healthcare announced their collaboration with BirchBioMed, Inc.

BirchBioMed, Inc., is a biomedical company focused on anti-scarring medications, to treat and prevent scarring more effectively for patients with keloids.

Read the full press release here.

The Benefits of SRT

Along with eliminating the risks for post-surgical infections and complications, the SRT-100™ provides patients and physicians with a safe and effective treatment option that offers many benefits, including:

  1. 95%+ cure rates that rival surgery
  2. No anesthesia, cutting, bleeding, stitching or pain
  3. No downtime or lifestyle restrictions
  4. Super cosmesis, no unsightly scarring
  5. No need for post-treatment reconstructive surgeries